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Background. Consistent difference in graft survival after re-
nal transplantation has been shown when cadaveric transplants
are compared to the living related donor situation, in favor of
the latter. Recently, evidence has been put forward that brain
death has significant effects on the donor organ quality. In this
study, we aimed to assess the relation between brain death–
induced hemodynamic instability in combination with the dura-
tion of brain death on the function and immunogenicity status
of potential donor kidneys.
Methods. In Wistar rats, short-term (1 hour) or long-term
(6 hours) brain death in the presence or absence of hemody-
namic stability was applied. Sham-operated rats served as con-
trols (1 hour and 6 hours). Organ function was studied by moni-
toring serum creatinine, lactate dehydrogenase (LDH), lactate,
and total protein content. Expression of cell adhesion mole-
cules [intercellular adhesion molecule-1 (ICAM-1) and vas-
cular cell adhesion molecule-1 (VCAM-1)] and the influx of
leukocytes in the kidney assessed the immunologic status of
the kidney.
Results. Progressive organ dysfunction was most pronounced
in hemodynamically unstable brain-dead donors reflected by
increased serum creatinine levels. Regardless of hemodynamic
status, a progressive inflammatory activation by cell adhesion
molecule expression and an influx of leukocytes could be ob-
served in kidneys of brain-dead rats compared with nonbrain-
dead controls.
Conclusion. Brain death causes progressive kidney dysfunc-
tion. Also, inflammatory responses reflecting tissue injury are
caused by brain death. When hemodynamic instability in the
brain-dead donor is not corrected, kidney dysfunction is en-
hanced and immune activation occurs faster and is more
profound. The observed changes may predispose the graft for
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additional ischemia/reperfusion injury during the transplant
process and hence accelerate rejection of the graft after trans-
plantation.
When results after transplantation of kidneys derived
from living (un)related donors are compared with those
obtained from brain-dead donors, a consistent inferior
survival is observed in the latter [1–3]. Multiple factors
possibly responsible for this difference in survival have
been studied over the years. First, in the past, the superior
human leukocyte antigen (HLA) matching in the living
related donor combination has always been regarded as a
prime factor for a better survival. HLA-identical siblings
have always shown the best graft survival; however, when
results of the non-HLA-identical living related transplant
combinations were compared to the inferior-matched liv-
ing unrelated combinations, graft survival was similar in
both groups [1, 4]. Also, despite the higher level of HLA
matching for cadaveric grafts compared to that of living
unrelated donor combinations, transplantations of well-
matched cadaveric kidneys are by far inferior to HLA
mismatched living related kidney grafts. Another major
factor and possibly as important is the quality of the donor
kidney after preservation. The difference in cold ische-
mia time between living (un)related and cadaveric trans-
plantation has been considered as a cause for the difference
in transplant results. Long cold ischemia time promotes
delayed graft function [5, 6] and organs with delayed
graft function show more acute rejection episodes and
a greater likelihood of developing chronic transplant dys-
function than organs with initial good function [7–9].
However, no significant effect of the duration of cold
ischemia could be shown with preservation times up to
24 to 28 hours [5, 6, 10], the time frame for most cadaveric
kidneys to be transplanted in the Eurotransplant Organ
Sharing System.
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A few years ago, the nonphysiologic state of brain
death prior to organ retrieval was considered a potential
cause for the inferior outcome after cadaveric vs. living
donor transplantation [11–14]. Since then, the effects
of brain death on donor organ quality have received
considerable attention and a number of groups has at-
tempted to better define its impact on short- and long-
term graft function. Several authors as well as our group
were able to demonstrate in animal models [11, 12, 15]
and in humans [16] a significant immunologic activation
of potential donor organs induced by brain death. In
addition, animal experiments have now shown that brain
death in the donor is responsible for an increased risk
of ischemia/reperfusion injury and a decreased graft sur-
vival of the kidney and liver [14, 17].
The exact effects of brain death, however, and, in
particular, its interdependence with brain death–induced
hemodynamic instability have not been unraveled yet.
In this study, we examined the effects of brain death as
such, as well as the impact of the duration of brain death
in relation to donor hemodynamic stability on function
and immunologic status of potential donor kidneys.
METHODS
Design of the study
To study short- and long-term effects of brain death
in the presence and absence of hemodynamic donor sta-
bility on kidney function and immunologic status, adult
male Wistar rats were used (HSD.Cpb:WU, 300 to 350
g body weight). All animals received care in compliance
with the guidelines of the institutional animal ethics com-
mittee according to the Experiments on Animals Act
(1996) issued by The Netherlands Ministry of Public
Health, Welfare, and Sports. Rats were randomly allo-
cated to six groups.
Controls. Two groups of six rats each served as sham-
operated nonbrain-dead controls and were killed 1 or
6 hours after onset of the experiment.
Brain-dead groups. In all rats of the other four groups,
brain death was induced as described below. Rats were
either killed 1 or 6 hours after the commencement of
the brain-dead state. Two groups, the 1-hour and 6-hour
so-called optimal (normotensive) donors (N  6 and
N  10, respectively) received donor management (he-
modynamic support to achieve normotension). The two
other brain-dead groups did not receive donor manage-
ment and remained hypotensive after brain-death induc-
tion, representing the 1 hour and 6 hour marginal (hypo-
tensive) donors (N  5 and N  7, respectively).
Anesthesia and ventilation
Halothane anesthesia was used in all procedures until
the moment of brain-death induction. Rats were intu-
bated and then ventilated using a Medec MK 78 infant
ventilator (Medec NL, Wormerveer, The Netherlands).
A mixture of nitrous oxide and oxygen was used for a
period up to 30 minutes after brain-death induction
(stroke rate 60 per minute, peak inspiratory pressure 12
to 14 mm Hg, 40% inspiratory phase, 10% plateau).
Subsequently, all rats were ventilated with 30% O2 in
air. The nonbrain-dead control groups remained anes-
thetized throughout the whole experiment.
Operative procedure
A laparotomy was performed through a midline inci-
sion for implantation of a telemetric device for continu-
ous registration of mean arterial pressure (MAP) and
heart rate (Chronic Use TA11PA-c40 Implant) (Data
Science, Int., St. Paul, MN, USA). The tip of the teleme-
try implant was subsequently inserted into the abdominal
aorta just proximal to the bifurcation. A catheter was
introduced in the bladder after which the bladder and
abdomen were closed.
Brain-death induction
Through a frontolateral trepanation (1  1 mm with
a dental drill), a balloon catheter (Fogarty 14G) (Baxter
Health Care Corp., Irvine, CA, USA) was introduced in
the extradural space with the tip pointing caudally. In-
flating the balloon for 1 minute increased the intracranial
pressure, thereby inducing rapid progressive brain injury
and leading to immediate brain death. A sharp rise and
then a subsequent drop of blood pressure and heart rate
defined initiation of brain death. The state of brain death
was confirmed 30 minutes after induction of brain death
by the absence of corneal reflexes and by an apnea test.
Donor management
As indicated in the design of the study, rats in the so-
called optimal donor groups received donor manage-
ment. Normotension in these groups was obtained by
Gelofusin infusion (Vifor Medical SA, Basel, Switzer-
land) in the tail vein at a rate of 0.5 mL per minute. A
MAP  80 mm Hg was considered normotensive [18].
In these two groups, treatment started 15 minutes after
brain-death induction allowing a period of hemodynamic
stabilization after brain-death induction. If the infusion
of Gelofusin was insufficient to maintain normotension,
norepinephrine was administered in a dose of 0.01g/mL.
Animals in the 1-hour and 6-hour marginal donor groups
were not treated for hypotension during the whole study
period. Control animals received 0.5 mL Gelofusin intra-
venously immediately after sham operation.
Sampling procedure and biochemical determinations
Just prior to termination of the experiment, a relapa-
rotomy was performed to collect serum for biochemical
analysis and to take biopsies from the kidney. Tissue
samples were snap-frozen in isopentane (80C).
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Table 1. Primary antibodies used in this study for immunohistochemical analysis of rat kidney tissue sections
Clone Reactive with Source
5F10 VCAM-1 Dr. R. Lobb, Cambridge, Massachusetts
1A29 ICAM-1 Dr. M. Miyasaka, Osaka, Japan
OX1 CD45 European Collection of Animal Cell Cultures
R73 T-cell receptor Dr. Hunig, Wurzburg, Germany
OX8 CD8 European Collection of Animal Cell Cultures
0X35 CD4 European Collection of Animal Cell Cultures
HIS48 PMN Department of Histology, Groningen University, The Netherlands
NKR-P1A NK cells Pharmingen, San Diego, California
ED-1 Naive Mφ Serotec, Amsterdam, The Netherlands
ED-2 Tissue Mφ Serotec, Amsterdam, The Netherlands
Abbreviations are: VCAM-1, vascular cell adhesion molecule-1; ICAM-1, intercellular adhesion molecules; PMN, polymorphonuclear cells; NK, natural killer.
Blood samples were analyzed in a routine fashion. As
an indicator of loss of kidney function, serum creatinine
concentration was used. Serum lactate dehydrogenase
(LDH) was used as an indicator of general (dys)function
of the donor. Lactate concentration was determined to
identify the occurrence of acidosis. Total protein content
of the serum was used to analyze hemoconcentration or
hemodilution (Mega Merck, Darmstadt, Germany).
Immunohistochemical analysis of kidney tissue
Snap-frozen kidney tissue was cryostat-cut at 6 m.
As changes in endothelial cell activation status are con-
sidered significant factors for success or failure of the
graft [19, 20], endothelial expression of cell adhesion
molecules [intercellular adhesion molecule-1 (ICAM-1)
and vascular cell adhesion molecule-1 (VCAM-1)] was
studied. Endothelial expression of these cell adhesion
molecules facilitates leukocyte recruitment. This leuko-
cyte recruitment was analyzed by staining for CD45 (leu-
kocyte-common antigen). Leukocytes in the glomeruli
and interstitium were differentiated by staining for the
T-cell receptor, CD8, CD4, polymorphomononuclear cells
(PMNs), natural killer (NK) cells, circulating macrophages
(ED-1), and resident (mature) macrophages (ED-2). See
Table 1 for primary antibodies used.
After thorough washing, the sections were incubated
with appropriate horseradish peroxidase–conjugated sec-
ondary antibodies (Dako, Glostrup, Denmark) and color
was developed using 3-amino-9-ethylcarboxide (AEC)/
H2O2. Sections were counterstained using Mayer’s hema-
toxylin (Merck, Darmstadt, Germany). Routine hema-
toxylin and eosin staining was also performed on tissue
sections of all rats.
Quantitation of immunohistochemical staining was as-
sessed by light microscopy. VCAM-1 and ICAM-1 stain-
ing was scored as negative (no staining) or weakly (),
moderately (), or strongly positive (). Micro-
scopic examination and comparison were always per-
formed with biopsies simultaneously stained. Three indi-
viduals independently scored all samples. Quantitation
of stained cells in the sections stained for CD45, T-cell
receptor, CD8, CD4, PMNs, NK cells, and macrophages
was performed by counting the mean number of posi-
tive cells per 25 glomeruli and for the interstitium by
counting the mean number of positive cells per 25 areas
of 0.025 mm2 in the cortex at 400 magnification.
Statistical analysis
All results are expressed as mean  standard error of
the mean (SEM). Statistical analysis comparing different
treatment modalities was performed using the Mann-
Whitney U test with P 	 0.05 considered significant.
Statistical analysis comparing different time points was
performed using the Kruskal-Wallis test with P 	 0.05
considered significant.
RESULTS
Effects of brain death and donor management on
blood pressure and heart rate
The effects of brain death and donor management on
the hemodynamic stability are shown in Figure 1. Before
brain-death induction, no differences in heart rate and
MAP were observed between any of the groups. In all
rats exposed to brain-death induction, a steep rise in
heart rate and MAP was recorded. Within 10 minutes
after brain-death induction, MAP decreased to a hypo-
tensive level of less than 80 mm Hg. The animals in both
marginal donor groups received no Gelofusin infusion
and consequently remained hypotensive, with mean
blood pressures of 55  5.3 mm Hg after 1 hour and
52  9.9 mm Hg after 6 hours of brain death. Before
infusion therapy, no differences were seen in MAP or
heart rate between the marginal and optimal donor
groups. In the optimal donor groups, normotension was
achieved in all animals with fluid administration within
5 to 7 minutes after starting Gelofusin infusion. This
resulted in a significantly increased MAP compared with
the marginal donor group. The mean volume of Gelo-
fusin infused in the 1-hour and 6-hour optimal donor
group was respectively 3.3  0.6 mL and 10.1  1.4
mL. No norepinephrine administration was necessary to
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Fig. 1. Changes in mean arterial pressure (MAP) in rats after induction
of brain death are shown: immediate hypertension followed by hypoten-
sion. Next, due to the absence or presence of donor management either
hemodynamic instability persists (marginal donors) or hemodynamic
stability is achieved (optimal donors). MAP is expressed as mean 
SEM. The shaded area shows the normal range of MAP in nonbrain-
dead control rats. The cut-off point of hypotension (	80 mm Hg) is
represented by the dotted line.
maintain normotension in the 1-hour brain-death group.
In the optimal 6-hour group, seven of ten rats needed
additional support with norepinephrine infusion to re-
main normotensive.
In the brain-dead rats, diabetes insipidus occurred and
diuresis increased with duration of brain death from
0.8  0.3 mL/kg/hour in the first hour to 3.7  1.4 mL/
kg/hour after 6 hours. In the nonbrain-dead control rats,
diuresis remained stable between 0.70 and 1.20 mL/
kg/hour.
Effects of brain death and hemodynamic stability on
serum parameters
Results of biochemical determinations are shown in
Table 2. Serum creatinine concentration was significantly
increased in the 1-hour and 6-hour marginal donor groups
compared with controls. In optimal donors, the serum
creatinine concentration was increased after 6 hours of
brain death only. The increase in creatinine concentration
in optimal donors was significantly lower compared to
that in marginal donors (see Fig. 2). Serum parameter
LDH was corrected for hemodilution or hemoconcentra-
tion as assessed by the total protein content of the serum.
In all groups, the LDH concentration was elevated at
1 hour after operation. In the sham-operated controls,
the LDH concentration returned to normal within 6
hours after operation. In marginal donors, the LDH con-
centration increased to a higher level in the 6-hour brain-
death group, indicating progressive loss of cell viability.
In optimal donors, the LDH concentration remained
elevated and was significantly higher 6 hours after onset
of brain death than in controls. The increase in concen-
Fig. 2. Creatinine concentration reflecting kidney (dys)function in non-
brain-dead control rats, marginal, and optimal brain-dead donors 1 hour
and 6 hours after brain-death induction. All results are expressed as
mean  SEM. aP 	 0.05 compared to 1 hour; bP 	 0.05 compared to
controls; cP 	 0.05 compared to optimal donors.
tration in marginal donors was significantly higher than
in optimal donors. Lactate concentrations in marginal
donors were significantly increased at all time points
compared to optimal donors and controls.
Immunohistochemistry of kidney tissue
Tables 3 and 4, as well as Figure 5, show the results
of the immunohistochemical analysis of the kidney glo-
meruli and interstitium with respect to vascular activa-
tion status and leukocyte infiltration pattern.
Endothelial cell activation. Neither in kidneys from
control rats, nor in kidneys retrieved from marginal and
optimal donors, VCAM-1 expression was visible in the
microvessels lining the proximal and distal tubuli. Only
after 6 hours of brain death under both normotensive
and hypotensive conditions, some reactivity (scored as
weak) within the glomeruli could be detected. Likely,
this staining was associated with glomerular blood vessel
endothelium.
In normal rat kidney tissue, ICAM-1 expression was
low in glomerular endothelium (scored as weak, exempli-
fied in Figure 5 1-hour and 6-hour control biopsies).
Similarly, in marginal as well as in optimal donors, glo-
merular endothelium expression of ICAM-1 was scored
as weak (Fig. 5). In contrast, especially the microvascula-
ture, lining of the tubuli was more strongly expressing
ICAM-1 in both the marginal and optimal donor kidneys
(both moderate and strong staining patterns of inter-
stitial vasculature are exemplified in Fig. 5, hypotensive
and normotensive kidneys). This staining pattern was ob-
served throughout the kidney. Also, endothelium covering
larger venules stained moderately to strongly positive for
ICAM-1 throughout the kidney. Arterial endothelium was
always negative for ICAM-1 expression (larger venule
and artery staining patterns are not shown).
Leukocyte infiltration. A significant increase in infil-
trating leukocytes (i.e., CD45-positive cells) in glomeruli
of all brain-dead rats was observed (Fig. 3). In the mar-
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Table 2. Biochemical serum parameters reflecting organ dysfunction in nonbrain-dead control rats, hypotensive (marginal), and
normotensive (optimal) brain-dead donors 1 hours and 6 hours after brain-death induction
Control Marginal Optimal
1 hour 6 hours 1 hour 6 hours 1 hour 6 hours
Na mmol/L 1380.5 1400.7a 1392.2 1391.6c 1400.9 1451.7a,b
K mmol/L 5.20.2 4.90.2 6.30.4 9.61.2a,b,c 5.90.3 5.90.5
Creat lmol/L 592.6 432.2a 873.1b,c 17837a,b,c 605.8 9825b
LDH U/L 1589240 41082a 1357350 30371008b 1603256 1660421b
Lactate mmol/L 3.40.4 1.20.1 4.70.7c 4.91.1b,c 2.20.7 2.20.8
LDH is lactate dehydrogenase. Values are mean  SEM. Serum parameter LDH is corrected for hemodilution or hemoconcentration as assessed by the total
protein content of the serum.
a P 	 0.05 compared to 1 hour; b P 	 0.05 compared to controls; c P 	 0.05 compared to optimal donors
Table 3. Immunohistochemical analysis of mean antigen expression of glomeruli associated endothelial cell activation reflected by
intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) (, no staining; , weakly; ,
moderate; , strong) and cellular infiltrate (number of antigen-positive cells per 10 glomeruli) in kidney tissue of
controls and animals subjected to brain death for 1 hours or 6 hours
Control Marginal Optimal
1 hour 6 hours 1 hour 6 hours 1 hour 6 hours
VCAM-1      
ICAM-1      
CD45 13.51.5 14.91.5 36.74.8b,c 47.65.8b,c 19.32.8 21.61.7b
T-cell receptor 1.76.6 1.10.1 3.40.6b 4.40.5b,c 2.20.3 1.60.4
CD8 2.40.6 2.10.2 4.60.7 7.31.4b,c 3.11 2.60.3
CD4 80.8 16.42.8a 14.52.8b,c 9.42.9b,c 6.41.4 1.90.3a,b
Polymorphomononuclear cells 11.71.7 9.21.3 23.34.9b,c 40.15.2b 14.71.9 31.64.4a,b
Natural killer cells 5.34.1 1.70.4 3.80.5b 4.51.1 2.30.4 1.90.4
ED-1 14.20.9 20.31.8a 26.42.9b 28.63.5b 18.12.0 25.62.0a
ED-2 91 9.40.7 15.42.1b 22.43.4b 12.01.2 20.32.2a,b
Values are mean number of 25 studied glomeruli at 400 magnificationSEM.
a P 	 0.05 compared to 1 hour; b P 	 0.05 compared to controls; c P 	 0.05 compared to optimal donors. See Methods section for details of grading.
Table 4. Immunohistochemical analysis of mean antigen expression of endothelial cell activation by intercellular adhesion molecule-1
(ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) (, , , ) and antigen-positive cellular infiltrate
(number of antigen-positive cells per 10 microscopic fields) in the kidney cortical interstitium of controls and
animals subjected to brain death for 1 hour or 6 hours
Control Marginal Optimal
1 hour 6 hours 1 hour 6 hours 1 hour 6 hours
VCAM-1      
ICAM-1      
CD45 16.33.5 23.33.1 38.68.2b 53.95.8b 21.81.9 33.33.5
T-cell receptor 11.79.6 14.81.6 21.54.1 20.31.9b 12.71.7 14.31.1
CD8 23.11.5 23.32.2 27.52.8c 29.72.2b,c 18.71.9 15.71.3b
CD4 9.27.3 12.69.9a 12.738.4 11.426.5 8.112.8 7.511.5b
Polymorphomononuclear cells 5.20.8 30.3 8.51.2c 16.81.4a,b,c 4.10.8 8.21.4a,b
Natural killer cells 10.91.9 9.72.2 9.12.7 11.72.6 13.82.4 121.3
ED-1 141.4 12.31.9 271.2b,c 25.81.9b 18.32.4 21.91.9b
ED-2 6.20.5 6.90.7 17.41.9b,c 20.91.9b,c 11.30.8b 14.51.2a,b
Values are mean number of antigen positive cells per 25 microscopic fields at 400 magnification  SEM.
a P 	 0.05 compared to 1 hour time point; b P 	 0.05 compared to pertinent controls; c P 	 0.05 compared to optimal donors. See Methods section for details of
grading.
ginal donor groups, the number of infiltrating leukocytes
was already significantly increased 1 hour after induction
of brain death, and the accumulation increased with du-
ration of brain death. In the optimal donor groups, after
6 hours of brain death, the mean number of leukocytes
per glomerulus was increased. Compared to marginal
donors, the increase in leukocyte infiltrates was lower in
optimal donor kidneys. Leukocyte infiltrates in the glo-
meruli of marginal brain dead donors were composed
of PMNs (i.e., HIS48-positive cells) and CD8-positive
T lymphocytes (see Fig. 3). In contrast, in optimal do-
nors, only an influx of PMNs in the glomeruli had oc-
van der Hoeven et al: Brain death and kidney viability 1879
Fig. 3. Quantitative immunohistochemical analyses of expression of cellular infiltrate per 10 glomeruli in kidney tissue of control animals and
animals subjected to brain death for 1 hour and 6 hours. aP 	 0.05 compared to 1-hour time point; bP 	 0.05 compared to pertinent controls; cP
	0.05 compared to optimal donors.
Fig. 4. Immuhistochemical analysis of the presence of monocytes and
macrophages in the glomeruli of potential donor kidneys. ED-1 stains
antigen in all monocytes and macrophages, thereby reflecting residential
cells and cells recruited from the circulation, whereas ED-2 stains resi-
dent macrophages alone.
curred. In the interstitium, a virtually similar response
was observed with the exception that an increased amount
of CD45-positive cells was detected in the normotensive
brain-dead rats. The increase in T lymphocytes in the inter-
stitium of marginal donors consisted of CD8-positive
cells. The number of PMNs was increased in marginal do-
nors after 1 hour of brain death and increased further
with duration of brain death, whereas in optimal donors
only after 6 hours of brain death the amount of PMNs
was significantly increased. No significant difference in
the amount of NK cells was detected in any of the groups
in the glomeruli or the interstitium.
The mean number of resident monocytes and macro-
phages per glomerulus has been shown to be between
one and two [21], which corresponds well with the ob-
served numbers in our nonbrain-dead controls. In the
kidneys of hypotensive brain-dead rats, a significant in-
crease in monocytes and macrophages (i.e., ED-1–posi-
tive cells) [22] was observed in the glomeruli (Fig. 4). In
normotensive brain-dead donors, the total number of
monocytes and macrophages was not significantly in-
Fig. 5. Microscopic analysis of immunocytochemical staining of rele-
vant primary antibodies are shown in liver tissue of nonbrain-dead
control rats, marginal, and optimal brain-dead donors after 1 hour
and 6 hours, respectively. Abbreviations are: ICAM-1, intercellular
adhesion molecule-1; VCAM-1, vascular cell adhesion molecule-1.
creased compared to nonbrain-dead controls. The num-
ber of ED-2–positive macrophages was, however, sig-
nificantly increased after 6 hours of brain death. In the
interstitium an increase in ED-1–positive cells was found
after 1 and 6 hours of brain death in both marginal and
optimal donors. Also, the amount of ED-2–positive cells
was significantly increased in both groups compared to
nonbrain-dead control rats.
DISCUSSION
A few years ago, we and others hypothesized that brain
death in the donor could be an important factor contrib-
uting to the decreased graft survival of cadaveric organs
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compared with those of living donors. Since then, a num-
ber of studies have reported the effects of brain death
on donor organ quality and have attempted to better un-
derstand the pathophysiologic changes that occur during
this agonal phase [14, 17, 23–27]. It has become clear
now that brain death has a detrimental effect on donor
organ viability and renders it more susceptible to ische-
mia/reperfusion injury followed by a lower graft survival
[14]. Thus, means to modulate brain death–related injury
is becoming important as Pratschke et al [28] showed for
the first time.
To unravel the complex phenomenon of brain death,
we have focused in this study on the effect of the duration
of brain death and the influence of hemodynamic stabil-
ity in the organ donor on the cellular activation and func-
tion of potential donor kidneys.
Hemodynamic stability and brain death
Hemodynamic instability is inevitably encountered dur-
ing brain death. After the onset of brain death and a tem-
porary burst of sympathetic activation, parasympathetic
stimuli prevail. This leads to a neurogenic shock in the
potential organ donor. During neurogenic shock, hypo-
tension with hypoperfusion in the donor has detrimental
effects on posttransplant kidney function [6, 29]. There-
fore, in the clinical setting of donor management, normo-
tension is maintained as good as possible by fluid admin-
istration and vasoactive drugs. Until now, experiments
that have studied the effects of brain death, however,
have mostly been performed without correction of brain
death–induced hypotension. These experiments have
therefore not been able to unravel the effects of brain
death as such and its interdependence with hypotension.
In the current study, we addressed this issue by adminis-
tering hemodynamic support to a subset of brain-dead
donor rats. To our knowledge, so far, only one other group
has made adaptations to their experimental brain death
model to reach normotension [30]. By increasing the
time to fully inflate the intracranially placed balloon cath-
eter, less profound hemodynamic alterations occurred
during the induction of brain death, leading to persistent
normotension without hemodynamic support. This model,
however, does not reflect the hemodynamic alterations
observed in human donor studies in our hospital. In 95%
of our human brain-dead donors, the exact time of brain
death can be traced by the abrupt hemodynamic changes
and the (increased) need for hemodynamic stabilization
immediately thereafter, exactly as we have observed in
our animal model as well. We feel that our brain death
set-up in the animal as reported here, therefore, mimics
more closely the clinical situation.
Effects of brain death on the biochemical status
of the donor
Progressive kidney dysfunction is induced by the se-
quence of events resulting from brain death as shown
by the increased creatinine levels. Normotension after
inducing brain death, as in the optimal donors, reduces
the severity of kidney dysfunction, but does not fully
prevent it (43mol/L vs 178 mol/L vs 98 mol/L creati-
nine in controls, hypotensive, and normotensive brain-
dead rats, respectively). High creatinine levels in the
donor are an unfavorable sign for graft viability as they
are associated with inferior graft survival rates compared
to grafts from ideal donors [5, 31]. In addition, brain
death in the donor causes time-dependent general dys-
function, as indicated by the elevated LDH concentra-
tion, being again more pronounced in hemodynamic un-
stable brain-dead donors.
The lactate serum levels were significantly increased
in hypotensive brain-dead animals only. These data are
in accordance with those reported by Novitzky et al [32].
In their baboon experiments, no hemodynamic support
was given during brain death and similar elevated lactate
levels were measured. Based on the current data, we can
state that the observed increase in serum lactate concen-
tration is an effect of concomitant hypotension and not
of brain death itself.
Effects of brain death on the immunologic status
of the kidney
Adhesion molecules play a pivotal role in modifying
the immunologic status of the donor organ [33]. Brain
death induces adhesion molecule expression as shown
by the expression of ICAM-1 on proximal tubules in bi-
opsies of brain-dead rats. A similar expression pattern
has previously been described during episodes of in-
flammation in the kidney [34, 35]. Takada et al [11] also
described activation of cell adhesion molecules in rats
after 6 hours of brain death by staining for P- and
E-selectin. In human renal biopsies derived from brain-
dead donors, Koo et al [16] and Fuggle et al [36] also
found induction of cell adhesion molecule expression.
High levels of proximal tubular ICAM-1 expression in
62% of the cadaver donor kidneys was observed, whereas
tubular ICAM-1 expression on biopsies of living related
donors was absent [16]. In contrast to our findings in
rats, however, Koo et al, Fuggle et al, and Rice et al [37]
observed constitutive VCAM-1 expression on Bowman’s
capsule in all the renal biopsies analyzed. High levels of
proximal tubular VCAM-1 were detected in cadaveric
biopsies, while living related biopsies remained negative
in all cases. Also, our preliminary data of human donor
renal biopsies show endothelial cell activation as assessed
by E-selectin staining (unpublished data). Mild to mod-
erate E-selectin expression could be observed in intertu-
bular capillaries of proximal and distal tubules in 5 of
29 (17%) kidney biopsies taken after explantation from
living donors. None of these biopsies showed strong ex-
pression of E-selectin. In contrast, in 15 of 30 kidney bi-
van der Hoeven et al: Brain death and kidney viability 1881
opsies taken from brain-dead donors, moderate to strong
staining could be observed.
Leukocyte recruitment into the kidney occurred in our
experiments presumably facilitated by up-regulated cell
adhesion molecule expression. A significant increase in
infiltrating leukocytes (i.e., CD45-positive cells) was ob-
served in glomeruli and interstitium of the potential do-
nor kidneys of hemodynamic unstable brain-dead do-
nors. Also, in normotensive brain-dead rats, an increased
amount of CD45-positive cells was observed in the glo-
meruli after 6 hours of brain death. Hemodynamic insta-
bility in the donor was accompanied by an additional
influx of CD8-positive T lymphocytes in both glomeruli
and interstitium. This finding seems to contradict data re-
ported by Takada et al [11], who concluded that brain
death induced an influx of CD8-positive T cells in kidney
tissue. In their interesting study, however, immunohisto-
chemical analysis of hypotensive brain-dead rats were
compared to those of hypotensive nonbrain-dead con-
trols. It was assumed that the T-lymphocyte recruitment,
which was not observed in hypotensive controls, was an
effect of brain death. By subtracting the observed effects
seen in the hypotensive nonbrain-dead control rats from
those of hypotensive brain-dead animals, however, syn-
ergistic effects of brain death and hypotension could not
be distinguished.
This study shows that brain death has definite effects
on organ function and on the immunologic status of the
donor kidney prior to organ retrieval. The immunologic
changes observed relate well to those observed by Lu et al
[38] after injury of the potential graft. In this respect,
recognition of injury, together with recognition of spe-
cific nonself alloantigens, is required for allograft rejec-
tion. The first step of injury leading to rejection is consid-
ered to induce expression of adhesion molecules and
subsequent recruitment of inflammatory cells into the
graft as observed in the kidney biopsies of this study.
The next phase toward allograft rejection, in which the
influx of T cells is assisted by dendritic cells and costimu-
latory signaling, cannot be shown since in this study no
transplant model was used. Considering the transplant
results of Kusaka et al [17], however, it is likely that this
immunologic reaction will prevail after transplantation
leading to initiation of rejection. Furthermore, in the
human renal biopsy study of Koo et al [16], with immuno-
logic findings comparable to the data presented here,
expression of pretransplant cell adhesion molecules in
cadaver donor kidneys was significantly associated with
early acute rejection following transplantation.
CONCLUSION
Brain death induces progressive organ dysfunction,
which is more severe when hemodynamic instability is not
corrected during this nonphysiologic phase prior to or-
gan retrieval. Furthermore, brain death induces progres-
sive immune activation by cell adhesion molecule expres-
sion and influx of leukocytes, primarily PMNs. The influx
of inflammatory cells occurs faster and more pronounced
when hypotension persists during brain death–related
donor management. This study stresses the need for ade-
quate hemodynamic stabilization of the brain-dead or-
gan donor and suggests that the duration of the state of
brain death should be kept as short as possible.
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